MX2010003462A - TRATAMIENTO DE SINTOMAS DE INFECCION DE LAS VIAS RESPIRATORIAS SUPERIORES Y BIENESTAR PSICOLOGICO CON ß-GLUCANO. - Google Patents
TRATAMIENTO DE SINTOMAS DE INFECCION DE LAS VIAS RESPIRATORIAS SUPERIORES Y BIENESTAR PSICOLOGICO CON ß-GLUCANO.Info
- Publication number
- MX2010003462A MX2010003462A MX2010003462A MX2010003462A MX2010003462A MX 2010003462 A MX2010003462 A MX 2010003462A MX 2010003462 A MX2010003462 A MX 2010003462A MX 2010003462 A MX2010003462 A MX 2010003462A MX 2010003462 A MX2010003462 A MX 2010003462A
- Authority
- MX
- Mexico
- Prior art keywords
- respiratory tract
- upper respiratory
- tract infection
- infection symptoms
- psychological well
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/04—Drugs for disorders of the respiratory system for throat disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Molecular Biology (AREA)
- Nutrition Science (AREA)
- Otolaryngology (AREA)
- Physiology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Toxicology (AREA)
- Anesthesiology (AREA)
- Psychiatry (AREA)
- Diabetes (AREA)
- Rheumatology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Se llevaron a cabo estudios que implican diseños controlados con placebo, doble ciegos, para evaluar el efecto de composiciones de beta glucano en infecciones de las vías respiratorias superiores y en el bienestar psicológico. En el transcurso de los periodos de presentación de informes de estos estudios, los sujetos que estaban en los grupos de tratamiento informaron de menores síntomas de URTI, mejor salud general y una evaluación psicológica más positiva con base en el estudio POMS.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US97573407P | 2007-09-27 | 2007-09-27 | |
PCT/US2008/011249 WO2009042230A1 (en) | 2007-09-27 | 2008-09-29 | ß-GLUCAN TREATMENT OF UPPER RESPIRATORY TRACT INFECTION SYMPTOMS AND PSYCHOLOGICAL WELL-BEING |
Publications (2)
Publication Number | Publication Date |
---|---|
MX2010003462A true MX2010003462A (es) | 2010-08-18 |
MX340664B MX340664B (es) | 2016-07-20 |
Family
ID=40511769
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2010003462A MX340664B (es) | 2007-09-27 | 2008-09-29 | TRATAMIENTO DE SINTOMAS DE INFECCION DE LAS VIAS RESPIRATORIAS SUPERIORES Y BIENESTAR PSICOLOGICO CON ß-GLUCANO. |
Country Status (15)
Country | Link |
---|---|
US (1) | US20110112048A1 (es) |
EP (2) | EP2205250B1 (es) |
JP (2) | JP2010540531A (es) |
KR (3) | KR20160067982A (es) |
CN (3) | CN105326852B (es) |
AU (1) | AU2008305545B2 (es) |
CA (1) | CA2700922C (es) |
CO (1) | CO6321155A2 (es) |
ES (2) | ES2580159T3 (es) |
HK (1) | HK1166016A1 (es) |
MX (1) | MX340664B (es) |
MY (1) | MY156219A (es) |
PL (1) | PL3072518T3 (es) |
TR (1) | TR201807223T4 (es) |
WO (1) | WO2009042230A1 (es) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SK500492010A3 (sk) * | 2010-11-06 | 2012-06-04 | Pleuran, S.R.O. | Use of beta-D-glucane for decreasing undesirable effect of depression of immune response to excessive physical strain |
CN103783370B (zh) * | 2014-02-12 | 2015-05-20 | 北京同仁堂健康药业股份有限公司 | 一种保护呼吸道和肺部的组合物 |
CN115153023B (zh) * | 2014-07-02 | 2024-06-04 | 嘉康利公司 | 用于增强免疫的组合物和方法 |
CN106038582A (zh) * | 2016-05-06 | 2016-10-26 | 云南大学 | 以树突状细胞相关c型植物凝集素‑1为靶点的抗抑郁症药物及其筛选方法 |
WO2018156888A1 (en) | 2017-02-24 | 2018-08-30 | Biothera Pharmaceuticals, Inc. | Beta glucan immunopharmacodynamics |
US11872257B2 (en) | 2017-08-11 | 2024-01-16 | Biocodex | Saccharomyces boulardii for the treatment of mood disorders |
CA3079933A1 (en) | 2017-10-23 | 2019-05-02 | Nutrileads B.V. | Enzymatically hydrolysed pectic polysaccharides for treating or preventing infections |
WO2019112418A1 (en) | 2017-12-04 | 2019-06-13 | Nutrileads B.V. | Composition for use in the prevention or treatment of salmonellosis |
US20220132902A1 (en) * | 2020-08-12 | 2022-05-05 | Pharmavite, Llc | Prebiotic composition of pectin, beta-glucan, xylooligosaccharide and/or ashwagandha and a method of improving mood |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4992540A (en) | 1984-11-28 | 1991-02-12 | Massachusetts Institute Of Technology | Glucan composition and process for preparation thereof |
EP0490995A1 (en) | 1989-09-08 | 1992-06-24 | Alpha Beta Technology | Method for producing soluble glucans |
AU647751B2 (en) * | 1989-09-08 | 1994-03-31 | Alpha-Beta Technology, Inc. | Method for immune system activation |
US5811542A (en) | 1989-09-08 | 1998-09-22 | Alpha-Beta Technology, Inc. | Method for producing soluble glucans |
US5622939A (en) * | 1992-08-21 | 1997-04-22 | Alpha-Beta Technology, Inc. | Glucan preparation |
US5223491A (en) | 1989-11-09 | 1993-06-29 | Donzis Byron A | Method for revitalizing skin by applying topically water insoluble glucan |
US5576015A (en) | 1995-03-02 | 1996-11-19 | Donzis; Byron A. | Substantially purified beta (1,3) finely ground yeast cell wall glucan composition with dermatological and nutritional uses |
US6130244A (en) * | 1998-02-25 | 2000-10-10 | Abbott Laboratories | Product and method to reduce stress induced immune suppression |
JP2002209598A (ja) * | 2001-01-15 | 2002-07-30 | Kirin Brewery Co Ltd | 酵母由来可溶性多糖 |
US6939864B1 (en) * | 2001-07-09 | 2005-09-06 | Purdue Research Foundation | Animal feed compositions and methods of using the same |
US6503506B1 (en) * | 2001-08-10 | 2003-01-07 | Millenium Biotechnologies, Inc. | Nutrient therapy for immuno-compromised patients |
KR20030087383A (ko) * | 2002-05-08 | 2003-11-14 | 강상모 | 효모벽 추출물의 베타-글루칸을 이용한 건강증진 방법 |
DE202004013521U1 (de) * | 2004-08-30 | 2006-01-05 | Almapharm Christian F.A. Botzenhardt Gmbh + Co | Präparat aus beta-Glucan und Nukleotid zur Verabreichung an Tiere |
US20060084629A1 (en) * | 2004-10-15 | 2006-04-20 | Alvin Needleman | Immune system activating formula composed of selected long chain polysaccharides from natural sources |
JP2007190002A (ja) * | 2006-01-16 | 2007-08-02 | Elson Kk | ストレス適応形成を促進させる機能性飲食品 |
-
2008
- 2008-09-29 KR KR1020167014275A patent/KR20160067982A/ko active Search and Examination
- 2008-09-29 PL PL16165948T patent/PL3072518T3/pl unknown
- 2008-09-29 JP JP2010526967A patent/JP2010540531A/ja active Pending
- 2008-09-29 MY MYPI2010001341A patent/MY156219A/en unknown
- 2008-09-29 CA CA2700922A patent/CA2700922C/en active Active
- 2008-09-29 CN CN201510514507.3A patent/CN105326852B/zh active Active
- 2008-09-29 AU AU2008305545A patent/AU2008305545B2/en active Active
- 2008-09-29 ES ES08833584.9T patent/ES2580159T3/es active Active
- 2008-09-29 EP EP08833584.9A patent/EP2205250B1/en active Active
- 2008-09-29 ES ES16165948.7T patent/ES2675942T3/es active Active
- 2008-09-29 CN CN200880117733A patent/CN101873860A/zh active Pending
- 2008-09-29 MX MX2010003462A patent/MX340664B/es active IP Right Grant
- 2008-09-29 KR KR1020157013487A patent/KR20150064233A/ko active Search and Examination
- 2008-09-29 WO PCT/US2008/011249 patent/WO2009042230A1/en active Application Filing
- 2008-09-29 EP EP16165948.7A patent/EP3072518B1/en active Active
- 2008-09-29 CN CN2011102256964A patent/CN102309503B/zh active Active
- 2008-09-29 KR KR1020107009071A patent/KR20100077175A/ko not_active Application Discontinuation
- 2008-09-29 US US12/286,185 patent/US20110112048A1/en not_active Abandoned
- 2008-09-29 TR TR2018/07223T patent/TR201807223T4/tr unknown
-
2010
- 2010-04-27 CO CO10049552A patent/CO6321155A2/es not_active Application Discontinuation
-
2012
- 2012-07-11 HK HK12106829.0A patent/HK1166016A1/xx unknown
-
2015
- 2015-06-02 JP JP2015111978A patent/JP6078105B2/ja active Active
Also Published As
Publication number | Publication date |
---|---|
WO2009042230A1 (en) | 2009-04-02 |
CN105326852B (zh) | 2018-11-23 |
AU2008305545B2 (en) | 2014-07-17 |
US20110112048A1 (en) | 2011-05-12 |
CN102309503B (zh) | 2013-11-20 |
EP3072518B1 (en) | 2018-05-09 |
HK1166016A1 (en) | 2012-10-19 |
CN101873860A (zh) | 2010-10-27 |
CN105326852A (zh) | 2016-02-17 |
KR20150064233A (ko) | 2015-06-10 |
JP2015155475A (ja) | 2015-08-27 |
KR20160067982A (ko) | 2016-06-14 |
KR20100077175A (ko) | 2010-07-07 |
ES2580159T3 (es) | 2016-08-19 |
EP2205250A1 (en) | 2010-07-14 |
MY156219A (en) | 2016-01-29 |
CN102309503A (zh) | 2012-01-11 |
JP6078105B2 (ja) | 2017-02-08 |
ES2675942T3 (es) | 2018-07-13 |
EP2205250B1 (en) | 2016-05-04 |
CA2700922A1 (en) | 2009-04-02 |
PL3072518T3 (pl) | 2018-10-31 |
CO6321155A2 (es) | 2011-09-20 |
JP2010540531A (ja) | 2010-12-24 |
MX340664B (es) | 2016-07-20 |
EP2205250A4 (en) | 2011-04-06 |
AU2008305545A1 (en) | 2009-04-02 |
TR201807223T4 (tr) | 2018-06-21 |
EP3072518A1 (en) | 2016-09-28 |
CA2700922C (en) | 2016-07-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2010003462A (es) | TRATAMIENTO DE SINTOMAS DE INFECCION DE LAS VIAS RESPIRATORIAS SUPERIORES Y BIENESTAR PSICOLOGICO CON ß-GLUCANO. | |
MX353727B (es) | Tratamiento de sinucleinopatias. | |
SG10201901259RA (en) | Prebiotic formulations and methods of use | |
ZA200807879B (en) | Use of bifidobacterium longum for the prevention and treatment of inflammation | |
MX2007005587A (es) | Nueva composicion para facilitar el parto humano. | |
NZ591312A (en) | Treatment of pediatric acute lymphoblastic leukemia with a CD19 CD3 bispecific single chain antibody construct | |
UA100551C2 (en) | Synbiotic mixture | |
MX2009008825A (es) | Nuevos metodos de terapia anticolinergica. | |
WO2010086746A3 (en) | Compositions and methods of treating viral infections | |
PH12014501290A1 (en) | Methods and products to diagnose and treat heatiness | |
MY158310A (en) | Prevention and treatment of allergic diarrhoea | |
MX2010008280A (es) | Composicion para estimular la actividad de celula asesina natural. | |
ZA200703441B (en) | Coadministration of tigecycline and digoxin | |
UA108975C2 (uk) | Застосування співполімеру натрійкарбоксиметилцелюлози і госиполу в комплексній терапії пацієнтів з аутистичними розладами і когнітивними порушеннями | |
IL194353A0 (en) | Lysobactin amides | |
MY146657A (en) | Use of 4-cyclopropylmethoxy-n- (3,5-dichloro-1-oxido-pyridin-4-yl)-5-(methoxy) pyridine-2-carboxamide for the treatment of spinal cord traumas | |
MY148092A (en) | Use of 4-cyclopropylmethoxy-n-(3,5-dichloro-1-oxidopyridin-4-yl)-5-(methoxy)pyridine-2-carboxamide for the treatment of motor disorders related to parkinson's disease | |
FI20075861A0 (fi) | Enteroviruksen käyttö taudin diagnostiikassa, hoidossa ja ehkäisyssä | |
MX2009011214A (es) | Uso de 4-ciclopropilmetoxi-n-(3,5-dicloro-1-oxido-4-piridin-4-il)- 5-(metoxi)piridin-2-carboxamida para el tratamiento de los traumatismos craneales. | |
Mouradian | Gingival recession and grafting | |
TN2012000256A1 (en) | Therapeutic use of protein-polymer conjugates | |
UA46160U (en) | Massage arm-chair | |
RU2010140179A (ru) | Способ лечения пародонтита - способ иорданишвили | |
UA34817U (ru) | Способ медицинской реабилитации больных с синдромом повышенной усталости на фоне хронического тонзиллита | |
Lu et al. | Adequacy and Tolerability of Bowel Preparation by Klean-Prep for Colonoscopy in the Elderly |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |